Maisonneuve-Rosemont Hospital Université de Montréal

Our mission

Québec’s biggest HSC transplantation program

photo

Maisonneuve-Rosemont Hospital is home to Québec’s biggest, and Canada’s second biggest, hematopoietic stem cell transplantation program, performing close to 200 transplants annually. It is also among the four most respected centres involved in this field in North America.

The excellence of this program has gained both national and international recognition. In 2007, the Québec government named MRH as a centre of excellence for adult allogeneic hematopoietic stem cell transplantation within the Université de Montréal’s Réseau universitaire intégré de santé. In 2008, MRH was certified by the Foundation for Accreditation of Cellular Therapy (FACT) , which attests that the program has the highest level of quality in the world in terms of the manipulation of stem cells and patient care. Just recently, the Direction de la lutte contre le cancer of the Québec Department of Health and Social Services awarded the hospital’s Department of Hemato-Oncology, as well as its transplantation program, a Level 4 designation, the highest standard of excellence for a healthcare program.

The Maisonneuve-Rosemont Hospital’s Hematopoietic Stem Cell Transplantation Program is supported by seven highly experienced hematologist-transplant specialists and clinical researchers. Their mission is threefold:

Healthcare mission

Each year, the MRH’s Hematopoietic Stem Cell Transplantation Program welcomes very close to 200 patients and their families who are faced with potentially fatal diseases and for whom a stem cell transplant is often the sole hope for a cure… and survival.

It is the Transplantation Program team’s mission to provide these patients with very high-quality care, the product of the clinical expertise gained over the last 30 years and state-of-the-art clinical and scientific knowledge. While providing expert care, this team respects the uniqueness and dignity of every single patient in order to foster survival and improve his or her quality of life.

Our mission can be summarized as follows: Provide better treatment and care, as well as know and inform people better. We want to make our vision - "Stem cells offer life… and a future" -a true reality.

Research mission

There is a close working relationship between Maisonneuve-Rosemont Hospital’s hematologist-transplant surgeons and the researchers of the MRH’s Research Centre and UdeM’s Institute for Research in Immunology and Cancer (IRIC). This has led to an agreement for the promotion and development of a common strategy for basic and clinical research on blood cancers and cellular therapy. It is the mission of the MRH’s Hematopoietic Stem Cell Transplantation Program, along with the future Centre of Excellence for Cellular Therapy, to foster the development of innovative basic and clinical research on cellular therapy. To do so, the various stakeholders will build upon five areas of research:

All these avenues of basic and clinical research will enable improvement in the quality of care and post-transplant life, as well as in overall survival rates.

Teaching mission

Maisonneuve-Rosemont Hospital is also an educational institution renowned for its specialized training in hematology and oncology, welcoming residents from all four of Québec’s medical schools. MRH provides a dynamic, interactive training environment bridging the gap between the basic and clinical sciences and patient care.

Its teaching tradition is at the core of its development of an ultraspecialized postdoctoral training program in hematopoietic stem cell transplantation. Maisonneuve-Rosemont Hospital’s HSC Transplantation Fellowship Program is a two-year postdoctoral academic program recognized by the Université de Montréal that leads to a specialized degree (DEA) in transplantation. The purpose of this program is to train young medical specialists by providing them with a framework that will stimulate their acquisition of basic and clinical knowledge about HSC transplantation.